Ihre Abzeichen 52W-Spanne $9–$14 51% of range Analystenbewertung HOLD 9 analysts Kursziel $12 +2% upside P/E -5.1 ROE -12.4% Nettogewinnmarge -8.1%

MED Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne

03
Kurs $11.73
Marktkapitalisierung (MRQ) $131M
P/E (TTM) -5.1
EPS (TTM) $-2.32
Umsatz (TTM) $317M
Dividendenrendite 0.15%
ROE (TTM) -12.4%
52W-Spanne $9–$14

MED Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen

04
Spanne
Balken

Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.

Über MEDIFAST INC Common Stock Unternehmensübersicht von Wikipedia

05 · wikidata

Medifast, Inc. (NYSE: MED) is an American nutrition and weight loss company based in Baltimore, Maryland. Medifast produces, distributes, and sells weight loss and health-related products through websites, multi-level marketing, telemarketing, and franchised weight loss clinics.

Subsidiaries

The company owns five subsidiaries:

Jason Pharmaceuticals, Inc.

Take Shape for Life, Inc. (TSFL) (renamed Optavia from July 2017)

Jason Enterprises, Inc.

Jason Properties, LLC

Seven Crondall, LLC

History

William Vitale, a medical doctor, founded Medifast in 1980. He sold his products directly to other doctors, who in turn prescribed them to their patients alongside behavioural counselling techniques.

The company is publicly traded on the New York Stock Exchange (symbol: MED).

On July 17, 1995, HealthRite (predecessor of Medifast) changed its name from Vitamin Specialties Corp.

In 2000 the company pivoted to a direct-to-consumer marketing program with the help of Jason Pharmaceuticals and in 2001, the company changed its name to Medifast, Inc. In 2002, Retired Marine Colonel Bradley T. MacDonald, Chairman of the Board at the time, along with clinical specialist Dr. Wayne Scott Andersen, created Take Shape For Life as a personal Coach to the Client system and the company's “Habits of Health System.”

In October 2010, Medifast was ranked number 1 on Forbes magazine's list of "America's 100 Best Small Companies". The company was ranked 18th on the 2014 list.

Medifast was named one of Forbes's 100 Most Trustworthy Companies in America in 2016 and 2017.

In July 2017, Medifast changed the name of its subsidiary Take Shape For Life to Optavia and introduced a new line of products, Optavia Essentials, directly sold from Coaches to clients.

In October 2017, Medifast relocated its headquarters to Baltimore from Owings Mills, Maryland. The company is public with a market capitalization of $2.106 billion, as of June 2022.

In December 2023, Medifast announced a partnership with LifeMD, a provider of virtual healthcare services. Under the agreement, Medifast will use LifeMD's virtual platform to offer Medifast clients a clinically supported weight management program, including the option for prescription GLP-1 medications where clinically appropriate. In return, LifeMD will provide its patients with an independent Medifast Coach and additional lifestyle support services for weight management.

False advertising settlement

In September 2012, Medifast's subsidiary, Jason Pharmaceuticals, paid a $3.7 million USD civil penalty for false advertising. The Federal Trade Commission and United States Department of Justice said that advertisements for the "Medifast 5 & 1 Plan" low-calorie diet told consumers they could "lose up to 2-5 pounds per week", and that these weight-loss claims lacked a reasonable scientific basis, and were unsubstantiated. Under the settlement, any future claims made by the company must be backed by at least one human clinical study.

Quelle: Wikipedia (Englisch), CC BY-SA 4.0 · Auf Wikipedia ansehen ↗

Wikidata ↗

SektorConsumer products BrancheConsumer products Mitarbeiter380 LandUS

10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends

06
Umsatz$386M
2016-12-31 → 2025-12-31
EPS$-1.70
2016-12-31 → 2025-12-31
Freier Cashflow$1M
2016-12-31 → 2025-12-31
Nettogewinnmarge-8.1%
2016-12-31 → 2025-12-31
Bewertung & Kennzahlen 07–12

Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?

Kennzahl 5-Jahres-Trend MED 5-Jahres-Durchschnitt Peer-Median Fazit
P/E (TTM) -5.15-Jahres-Durchschnitt ≈23.6 ≈23.6 · ·
P/S (TTM) 0.45-Jahres-Durchschnitt ≈0.7 ≈0.7 0.8 Unterbewertet
K/B (MRQ) 0.75-Jahres-Durchschnitt ≈5.0 ≈5.0 2.2 Unterbewertet
Kurs / FCF (TTM) 32.75-Jahres-Durchschnitt ≈31.6 ≈31.6 · ·
Kurs / Cashflow (TTM) 14.95-Jahres-Durchschnitt ≈12.4 ≈12.4 13.9 Teurer
Price / Tangible Book (Kurs / Materieller Buchwert) 0.65-Jahres-Durchschnitt ≈5.0 ≈5.0 · ·

Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.

Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median

Dividenden Rendite, Ausschüttungsquote, Dividendenhistorie, 5-Jahres-CAGR

13
Dividendenrendite0.15%
Ausschüttungsquote-1.0%
Annualisierte Auszahlung≈$6.60Vierteljährlich bezahlt
Ex-DatumBetragWährungRendite
Sep 18, 2023$1,65USD≈8.2%
Jun 26, 2023$1,65USD≈7.3%
Mär 27, 2023$1,65USD≈6.6%
Dez 19, 2022$1,64USD≈5.7%
Sep 19, 2022$1,64USD≈5.4%
Jun 27, 2022$1,64USD≈3.2%
Mär 28, 2022$1,64USD≈3.5%
Dez 20, 2021$1,42USD≈2.6%
Sep 20, 2021$1,42USD≈2.5%
Jun 21, 2021$1,42USD≈1.9%
Mär 29, 2021$1,42USD≈2.3%
Dez 21, 2020$1,13USD≈2.3%
Sep 21, 2020$1,13USD≈3.1%
Jun 29, 2020$1,13USD≈3.0%
Mär 30, 2020$1,13USD≈5.9%
Dez 26, 2019$1,13USD≈3.1%
Sep 26, 2019$0,75USD≈3.0%
Jun 27, 2019$0,75USD≈2.5%
Mär 28, 2019$0,75USD≈1.9%
Dez 20, 2018$0,75USD≈1.8%

Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum

14
Durchschn. Überraschung 54.6%
Nächster Bericht Nov 02, 2026
ZeitraumBerichtEPS ActualEPS est.Überraschung
30. Juni 2026 Aug 10, 2026 $-0.28 $-0.66 57.3%
31. März 2026 $-0.19 $-0.53 63.8%
31. Dezember 2025 $-1.65 $-0.83 -99.2%
30. September 2025 $-0.21 $-0.39 46.7%
30. Juni 2025 $0.22 $-0.22 199.0%
31. März 2025 $-0.11 $-0.27 59.7%

Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow

15
Gewinn- und Verlustrechnung 15
Kennzahl Trend 202520242023202220212020201920182017201620152014
Revenue $386M$602M$1.07B$1.60B$1.53B$935M$714M$501M$302M$275M$273M$285M
Cost of Revenue $111M$158M$296M$458M$398M$237M$177M$121M$74M$69M$71M$76M
Gross Profit $275M$445M$776M$1.14B$1.13B$698M$537M$380M$228M$206M$201M$209M
R&D Expense $4M$5M$5M$4M$4M$3M$3M$2M$2M$2M$2M$1M
SG&A Expense $289M$442M$649M$956M$911M$564M$446M$311M$188M$179M$173M$179M
Operating Income $-14M$3M$126M$185M$216M$134M$91M$69M$40M$27M$29M$30M
Other Non-op $3M$-4M$-95.0K$-747.0K$119.0K$-140.0K$29.0K$179.0K$136.0K$-20.0K$326.0K$731.0K
Pretax Income $-6M$4M$129M$184M$216M$134M$92M$71M$40M$27M$30M$32M
Income Tax $13M$2M$29M$40M$52M$31M$14M$15M$13M$9M$10M$11M
Net Income $-19M$2M$99M$144M$164M$103M$78M$56M$28M$18M$20M$13M
EPS (Basic) $-1.70$0.19$9.13$12.82$14.01$8.74$6.62$4.67$2.32$1.51$1.68$1.04
EPS (Diluted) $-1.70$0.19$9.10$12.73$13.89$8.68$6.43$4.62$2.29$1.49$1.66$1.03
Shares (Basic) 10,981,00010,930,00010,884,00011,195,00011,705,00011,771,00011,771,00011,947,00011,924,00011,842,00011,959,00012,670,000
Shares (Diluted) 10,981,00010,963,00010,921,00011,276,00011,813,00011,850,00012,117,00012,079,00012,088,00011,947,00012,071,00012,778,000
EBITDA $29.0K$16M$140M$196M$223M$141M$96M$73M$44M$32M$36M·
Bilanz 24
Kennzahl Trend 202520242023202220212020201920182017201620152014
Cash & Equivalents $89M$91M$94M$88M$104M$164M$77M$81M$75M$52M$42M$24M
Short-term Investments $78M$71M$56M$0$5M$11M$16M$20M$24M$24M$25M$28M
Receivables ·····$584.0K$1M$1M$576.0K$1M$2M$2M
Inventory $20M$42M$55M$119M$180M$53M$49M$39M$19M$18M$13M$16M
Prepaid Expense $9M$10M$11M$16M$16M$6M$6M$5M$4M$4M$3M$3M
Current Assets $202M$214M$224M$223M$307M$234M$154M$146M$125M$101M$87M$82M
PP&E (Net) $31M$38M$51M$57M$56M$28M$26M$20M$19M$20M$29M$33M
PP&E (Gross) $99M$96M$99M$97M$89M$55M$49M$54M$52M$56M$75M$74M
Accum. Depreciation $68M$58M$47M$40M$33M$27M$23M$35M$33M$36M$46M$40M
Other Non-current Assets $8M$10M$15M$12M$6M$3M$353.0K$1M$2M$162.0K$205.0K$497.0K
Total Assets $248M$284M$310M$316M$398M$276M$195M$169M$146M$121M$116M$116M
Accounts Payable $38M$56M$86M$135M$163M$108M$76M$60M$37M$24M$23M$22M
Current Liabilities $43M$64M$92M$141M$170M$111M$79M$60M$37M$24M$24M$27M
Capital Leases $6M$10M$16M$20M$26M$7M$10M···$0$242.0K
Deferred Tax ········$208.0K$779.0K$4M$5M
Total Liabilities $49M$74M$108M$161M$196M$119M$90M$60M$37M$25M$28M$35M
Common Stock $11.0K$11.0K$11.0K$11.0K$12.0K$12.0K$12.0K$12.0K$12.0K$12.0K$12.0K$12.0K
Paid-in Capital $40M$33M$27M$22M$12M$8M·$9M$5M$3M$0$1M
Retained Earnings $158M$177M$175M$140M$190M$154M$169M$131M$104M$93M$89M$79M
Treasury Stock ··$0$6M$0$5M$64M$31M···$0
AOCI $234.0K$180.0K$248.0K$24.0K$111.0K$41.0K$25.0K$-173.0K$-160.0K$-165.0K$-62.0K$435.0K
Stockholders' Equity $199M$210M$201M$155M$202M$157M$105M$109M$107M$96M$89M$80M
Liabilities + Equity $248M$284M$310M$316M$398M$276M$195M$169M$146M$121M$116M$116M
Shares Outstanding 10,991,00010,938,00010,896,00010,873,00011,593,00011,772,00011,764,00011,868,00011,971,00011,871,00011,797,00012,075,764
Cashflow 16
Kennzahl Trend 202520242023202220212020201920182017201620152014
D&A $14M$13M$13M$11M$7M$4M$5M$4M$4M$5M$7M$8M
Stock-based Comp $8M$7M$8M$11M$10M$7M$5M$3M$4M$3M$3M$4M
Deferred Tax $11M$-7M$1M$-924.0K$-4M$601.0K$2M$-3M$-623.0K$-3M$-106.0K$286.0K
Restructuring ·········$1M··
Other Non-cash $-8M$10M$26M$30M$-82M$28M$-4M$155.0K$8M$2M$-737.0K·
Operating Cash Flow $7M$24M$148M$195M$95M$145M$84M$61M$43M$25M$29M$26M
CapEx $6M$7M$6M$17M$34M$6M$10M$5M$3M$3M$3M$7M
Investing Cash Flow $-8M$-27M$-61M$-11M$-29M$-1M$-6M$-1M$-3M$-2M$-189.0K$-3M
Net Debt Issued ·········$-219.0K$-255.0K·
Stock Repurchased $0$0$4M$126M$56M$5M$33M$30M··$11M$34M
Net Stock Activity $0$0$-4M$-126M$-56M$-5M$-33M$-30M··$-11M·
Dividends Paid $195.0K$715.0K$73M$72M$64M$53M$35M$23M$15M$12M··
Financing Cash Flow $-564.0K$-2M$-80M$-200M$-125M$-57M$-82M$-53M$-17M$-13M$-12M$-35M
Net Change in Cash $-2M$-4M$7M$-16M$-60M$87M$-4M$6M$23M$10M$18M$-12M
Taxes Paid $10M$-2M$34M$37M········
Free Cash Flow $1M$17M$141M$178M$60M$139M$74M$56M$40M$22M$27M·
Rentabilität 8
Kennzahl Trend 202520242023202220212020201920182017201620152014
Gross Margin 71.3%73.8%72.4%71.3%73.9%74.7%75.2%75.8%75.5%74.9%73.8%·
Operating Margin -3.7%0.48%11.8%11.6%14.2%14.3%12.8%13.8%13.1%9.8%10.5%·
Net Margin -4.8%0.35%9.3%9.0%10.8%11.0%10.9%11.1%9.2%6.5%7.3%·
Pretax Margin -1.5%0.63%12.0%11.5%14.2%14.4%12.9%14.1%13.4%9.9%10.9%·
EBITDA Margin 0.01%2.6%13.0%12.2%14.6%15.1%13.4%14.7%14.5%11.8%13.1%·
ROA -7.0%0.70%31.8%40.2%48.6%43.7%42.8%35.4%20.8%15.0%17.2%·
ROE -9.0%1.0%50.4%94.0%82.3%69.2%72.1%50.5%27.1%19.3%23.7%·
ROIC -23.7%0.76%48.4%93.0%81.1%65.4%73.3%50.1%25.1%18.4%21.3%·
Liquidität & Solvenz 2
Kennzahl Trend 202520242023202220212020201920182017201620152014
Current Ratio 4.73.32.41.61.82.11.92.43.44.13.7·
Quick Ratio 3.92.51.00.60.61.61.21.72.73.22.9·
Effizienz 3
Kennzahl Trend 202520242023202220212020201920182017201620152014
Asset Turnover 1.42.03.44.54.54.03.93.22.32.32.3·
Inventory Turnover 3.53.33.43.13.44.64.04.13.94.44.9·
Receivables Turnover ·····925.1583.1467.4307.2181.8166.2·
Pro Aktie 6
Kennzahl Trend 202520242023202220212020201920182017201620152014
Book Value / Share $18.10$19.21$18.49$14.26$17.47$13.36$8.91$9.19$9.07$8.09$7.51·
Revenue / Share $35.13$54.95$98.16$141.77$129.19$78.89$58.90$41.48$24.95$22.98$22.60·
Cash Flow / Share $0.62$2.23$13.52$17.26$8.00$12.25$6.95$5.03$3.58$2.12$2.44·
Cash / Share $8.13$8.31$8.67$8.06$8.99$13.91$6.54$6.86$6.27$4.42$3.56·
Dividend / Share $0.00$0.00$4.95$6.56$5.68$4.52$3.38$2.19$1.44$1.07$0.25$0.00
EPS (TTM) $-1.70$0.19$9.10$12.73$13.89$8.68$6.43$4.62$2.29$1.49$1.66$1.03
Wachstumsraten 8
Kennzahl Trend 202520242023202220212020201920182017201620152014
Revenue YoY -36.0%-43.8%-32.9%4.8%63.2%·······
Revenue CAGR 3Y -37.7%-26.6%4.7%·········
Revenue CAGR 5Y -16.2%···········
EPS YoY ·-97.9%-28.5%-8.3%60.0%·······
EPS CAGR 3Y ·-76.1%1.6%·········
Net Income YoY ·-97.9%-30.8%-12.5%59.5%·······
Net Income CAGR 3Y ·-76.6%-1.1%·········
Dividends Paid CAGR 5Y -67.4%···········
Bewertung (TTM) 13
Kennzahl Trend 202520242023202220212020201920182017201620152014
Revenue TTM $386M$602M$1.07B$1.60B$1.53B$935M$714M$501M$302M$275M$273M$285M
Net Income TTM $-19M$2M$99M$144M$164M$103M$78M$56M$28M$18M$20M$13M
Market Cap $117M$193M$732M$1.25B$2.43B$2.31B$1.29B$1.48B$836M$494M$358M·
P/E -6.392.77.49.115.122.617.027.130.527.918.332.6
P/S 0.30.30.70.81.62.51.83.02.81.81.3·
P/B 0.60.93.68.112.014.712.313.67.75.14.0·
P / Tangible Book 0.60.93.68.112.014.7······
P / Cash Flow 17.17.95.06.425.715.915.324.419.319.512.2·
P / FCF 94.011.35.27.140.216.617.426.620.922.013.5·
Dividend Yield 0.17%0.37%10.0%5.7%2.6%2.3%2.8%1.6%1.8%2.4%··
Earnings Yield -15.9%1.1%13.5%11.0%6.6%4.4%5.9%3.7%3.3%3.6%5.5%3.1%
Payout Ratio -1.0%34.2%73.5%49.9%38.9%51.7%45.4%41.5%55.5%66.7%··
Annual Payout $195.0K$715.0K$73M$72M$64M$53M$35M$23M$15M$12M··

Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt

Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre

16
Kennzahl 2025-12-312024-12-312023-12-312022-12-312021-12-31
Umsatz $386M $602M $1.07B $1.60B $1.53B
Bruttogewinnmarge % 71.3% 73.8% 72.4% 71.3% 73.9%
Betriebsgewinnmarge % -3.7% 0.48% 11.8% 11.6% 14.2%
Nettoergebnis $-19M $2M $99M $144M $164M
Verwässerte EPS $-1.70 $0.19 $9.10 $12.73 $13.89

Institutionelle Eigentümer (13F) 123 Einreicher · $106.7M gesamt · Stand 30. September 2026

17

Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.

Inhaber 123
Gehaltener Wert $106.7M
Neue Positionen 26
Geschlossene Positionen 24
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
Neue Positionen Geschlossene Positionen Erhöht Abgenommen Nettoveränderung der Aktien
26 (-5 vs. Vorquartal) 24 (+7 vs. Vorquartal) 47 (+12 vs. Vorquartal) 29 (-4 vs. Vorquartal) -931K

Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.

Institution Wert Aktien % der verfolgten 13F Typ
RENAISSANCE TECHNOLOGIES LLC $8.261.052 778.610 7,74% Aktien
VANGUARD GROUP INC $7.598.810 711.499 7,12% Aktien
Steamboat Capital Partners, LLC $7.498.076 706.699 7,03% Aktien
SUSQUEHANNA INTERNATIONAL GROUP, LLP $5.758.047 542.700 5,40% Kaufoption
TWO SIGMA INVESTMENTS, LP $5.107.452 481.381 4,79% Aktien
VANGUARD CAPITAL MANAGEMENT LLC $4.738.575 446.614 4,44% Aktien
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $4.212.128 396.996 3,95% Aktien
BlackRock, Inc. $3.920.427 369.503 3,68% Aktien
DIMENSIONAL FUND ADVISORS LP $3.855.669 363.394 3,61% Aktien
AMERICAN CENTURY COMPANIES INC $3.383.646 318.911 3,17% Aktien
MORGAN STANLEY $3.103.524 292.508 2,91% Aktien
GOLDMAN SACHS GROUP INC $2.579.132 243.085 2,42% Aktien
MARSHALL WACE, LLP $2.563.897 241.649 2,40% Aktien
AQR CAPITAL MANAGEMENT LLC $2.508.564 236.434 2,35% Aktien
CITADEL ADVISORS LLC $2.476.374 233.400 2,32% Kaufoption
Peapod Lane Capital LLC $2.361.531 222.576 2,21% Aktien
Lido Advisors, LLC $2.337.779 220.337 2,19% Aktien
Trexquant Investment LP $2.256.577 212.684 2,12% Aktien
JANE STREET GROUP, LLC $1.749.388 164.881 1,64% Aktien
COMMONS CAPITAL, LLC $1.590.609 149.916 1,49% Aktien
Quinn Opportunity Partners LLC $1.348.658 127.112 1,26% Aktien
GEODE CAPITAL MANAGEMENT, LLC $1.285.312 121.071 1,20% Aktien
BRIDGEWAY CAPITAL MANAGEMENT, LLC $1.242.198 117.078 1,16% Aktien
RBF Capital, LLC $1.156.490 109.000 1,08% Aktien
Walleye Trading LLC $1.145.880 108.000 1,07% Kaufoption
TWO SIGMA ADVISERS, LP $1.098.972 102.900 1,03% Aktien
JPMORGAN CHASE & CO $989.878 92.512 0,93% Aktien
D. E. Shaw & Co., Inc. $979.780 92.345 0,92% Aktien
BANK OF AMERICA CORP /DE/ $924.323 87.118 0,87% Aktien
Quantinno Capital Management LP $880.598 82.997 0,83% Aktien
Divisadero Street Capital Management, LP $847.092 79.839 0,79% Aktien
Virtus Family Office LLC $838.827 79.060 0,79% Aktien
TUDOR INVESTMENT CORP ET AL $806.689 76.031 0,76% Aktien
BNP PARIBAS FINANCIAL MARKETS $783.846 73.878 0,73% Aktien
FEDERATED HERMES, INC. $738.509 69.605 0,69% Aktien
Empowered Funds, LLC $701.374 66.105 0,66% Aktien
CITADEL ADVISORS LLC $696.016 65.600 0,65% Verkaufsoption
VANGUARD FIDUCIARY TRUST CO $672.006 63.337 0,63% Aktien
Atom Investors LP $659.083 62.119 0,62% Aktien
CITADEL ADVISORS LLC $597.873 56.350 0,56% Aktien
STATE STREET CORP $555.105 52.319 0,52% Aktien
GREAT LAKES ADVISORS, LLC $547.593 51.611 0,51% Aktien
UBS Group AG $532.866 50.223 0,50% Aktien
Engineers Gate Manager LP $528.686 49.829 0,50% Aktien
MILLENNIUM MANAGEMENT LLC $508.283 47.906 0,48% Aktien
SummerHaven Investment Management, LLC $507.529 47.835 0,48% Aktien
Centiva Capital, LP $471.424 44.432 0,44% Aktien
Susquehanna Portfolio Strategies, LLC $443.254 41.777 0,42% Aktien
Jump Financial, LLC $429.705 40.500 0,40% Aktien
SUSQUEHANNA INTERNATIONAL GROUP, LLP $422.278 39.800 0,40% Verkaufsoption

Alle 123 institutionellen Eigentümer anzeigen →

Aktivisten & 5%+-Eigentümer 8 Beteiligungen

18

Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.

Anmelder Eingereicht Beteiligung Status Zweck Einreichung
Parsa Kiai, Steamboat Capital Partners, LLC 21. August 2026 7,10% Änderung · SEC
Steamboat Capital Partners, LLC, Parsa Kiai 20. März 2026 6,00% Erste Einreichung Vorstandskampagne SEC
Engaged Capital Flagship Master Fund, LP, Engaged Capital Co-Invest X, LP, Engaged Capital Co-Invest X-A, LP, Engaged Capital Opportunities Fund, LP, Engaged Capital Flagship Fund, LP, Engaged Capital Flagship Fund, Ltd., Engaged Capital, LLC, Engaged Capital Holdings, LLC, Glenn W. Welling ×5 Einreichungen 15. Juli 2020 · Erste Einreichung · SEC
Engaged Capital Master Feeder II, LP, Engaged Capital Master Feeder I, LP, Engaged Capital I, LP, Engaged Capital I Offshore, Ltd., Engaged Capital II, LP, Engaged Capital II Offshore Ltd., Engaged Capital, LLC, Engaged Capital Holdings, LLC, Glenn W. Welling 3. Juni 2016 · Erste Einreichung · SEC
ModusLink Securities Corp., ModusLink Global Solutions, Inc. ×6 Einreichungen 19. Januar 2016 · Erste Einreichung · SEC
Engaged Capital Master Feeder I, LP, Engaged Capital Master Feeder II, LP, Engaged Capital I, LP, Engaged Capital I Offshore, Ltd., Engaged Capital II, LP, Engaged Capital II Offshore Ltd., Engaged Capital, LLC, Engaged Capital Holdings, LLC, Glenn W. Welling ×4 Einreichungen 1. September 2015 · Erste Einreichung · SEC
Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter 12. Dezember 2002 · Erste Einreichung · SEC
Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter 6. Mai 2002 · Erste Einreichung Passive Anlage SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Unternehmensinsider 52 Insider · 20 Führungskräfte · 28 Direktoren

19
Insider Rolle Letzte Aktivität Gehaltene Aktien Käufe 12m Verkäufe 12m Netto 12m
Michael S Mcdevitt Chief Executive Officer 5. Januar 2011 S 340.012 0 0 $0
James P. Maloney Chief Financial Officer 25. März 2026 A 73.033 0 0 $0
Timothy G Robinson Chief Financial Officer 20. Februar 2020 F 47.214 0 0 $0
Connors Brendan Chief Financial Officer 5. Januar 2011 S 91.484 0 0 $0
Mehrnaz Mona Ameli President, OPTAVIA 17. November 2017 F 10.809 0 0 $0
Margaret Macdonald Sheetz President & COO 1. April 2016 S 327.346 0 0 $0
Jonathan Barrett Mackenzie VP, Finance & CAO 25. März 2026 A 20.838 0 0 $0
Stephen Kyle Johnson VP, Finance & CAO 17. März 2021 A 665 0 0 $0
Joseph P Kelleman Vice President of Finance 20. Februar 2019 A 2.355 0 0 $0
Jason L Groves Executive VP & General Counsel 17. Februar 2015 A 21.697 0 0 $0
Jeanette M. Mills Executive Vice President 18. August 2014 S 20.116 0 0 $0
Guy Sheetz Executive Vice President 5. Februar 2014 A 410.430 0 0 $0
Dominick Vietri Executive Vice President 5. Februar 2014 A 3.804 0 0 $0
Brian Lloyd Executive Vice President 5. Februar 2014 A 1.865 0 0 $0
Donald Gould Executive Vice President 5. Februar 2014 A 6.804 0 0 $0
Brian Kagen Executive Vice President 5. Februar 2014 A 3.804 0 0 $0
Jeanne M Uphouse Executive Vice President 5. Februar 2014 A 3.804 0 0 $0
Brazdley T Macdonald Exec. Chairman of the Board 5. Januar 2011 S 579.521 0 0 $0
Leo Williams Executive Vice President 29. November 2010 S 15.000 0 0 $0
Robert J Hallock Corporate Vice President 18. November 2003 P 1.000 0 0 $0
Daniel R Chard Direktor 29. September 2026 S 130.609 1 2 $-47.575
Parsa Kiai Direktor 26. August 2026 P 20.270 8 0 $1.423.577
Jeffrey Matthew Rose Direktor 26. Mai 2026 A 18.419 0 0 $0
Elizabeth A. Geary Direktor 26. Mai 2026 A 31.225 0 0 $0
Andrea B Thomas Direktor 26. Mai 2026 A 35.697 0 0 $0
Ming Xian Direktor 26. Mai 2026 A · 0 0 $0
Scott Schlackman Direktor 26. Mai 2026 A 42.229 2 0 $62.950
Michael A. Hoer Direktor 25. Juni 2025 A 26.139 0 0 $0
Jeffrey J Brown Direktor 25. Juni 2025 A 38.578 0 0 $0
Kevin G Byrnes Direktor 11. November 2021 M 14.922 0 0 $0
Michael C Macdonald Direktor 1. Oktober 2020 S 266.179 0 0 $0
Carl E Sassano Direktor 17. Juli 2020 G 18.199 0 0 $0
Charles P Connolly Direktor 9. März 2018 M 41.374 0 0 $0
Welling Glenn W. Direktor 1. Dezember 2017 S 22.380 0 0 $0
Jorgene K. Hartwig Direktor 13. März 2017 M 9.808 0 0 $0
Barry B Bondroff Direktor 11. Juni 2015 S 14.533 0 0 $0
John P Mcdaniel Direktor 4. Juni 2015 S 18.289 0 0 $0
Jerry D Reece Direktor 17. Februar 2015 A 8.792 0 0 $0
Harvey C Barnum JR Direktor 17. Februar 2015 A 8.742 0 0 $0
Catherine T Maguire Direktor 17. Februar 2015 A 15.074 0 0 $0
Donald F Reilly Direktor 17. Februar 2015 A 0 0 0 $0
George Lavin Direktor 31. Juli 2013 D 24.785 0 0 $0
Joseph D Calderone Direktor 24. März 2009 A 21.700 0 0 $0
Carthy Dennis Mc Direktor 24. März 2009 A 17.075 0 0 $0
Michael J Mcdevitt Direktor 15. Februar 2007 A 17.400 0 0 $0
VISIUM BALANCED MASTER FUND, LTD. 10%-Eigentümer 31. Mai 2016 S 0 0 0 $0
Constance J. Hallquist · 6. Oktober 2023 S 2.152 0 0 $0
Shirley Macdonald · 12. Mai 2010 S 0 0 0 $0
Mary T Travis · 17. Dezember 2009 S 12.583 0 0 $0
Richard J Law · 13. August 2009 S 62.081 0 0 $0
RNI-NV Limited Partnership · 8. August 2005 S 1.088.830 0 0 $0
Scott Zion · 28. Juli 2004 P 185.000 0 0 $0

Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten

ETF-Besitz Gehalten von 18 ETFs

20

Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.

Fonds Gewicht Anteile Stand Quelle
VRIG · Invesco Actively Managed Exchange-T… 0,27% 5.000.000 2. Oktober 2026 Täglich
IWC · iShares Trust 0,03% 36.261 SH 11. September 2026 Täglich
VSS · VANGUARD INTERNATIONAL EQUITY INDEX… 0,01% 16.856 SH 19. August 2026 Täglich
DFSV · Dimensional ETF Trust 0,01% 60.623 NS 31. Juli 2026 N-PORT
DXUV · Dimensional ETF Trust 0,00% 2.012 NS 31. Juli 2026 N-PORT
DFAS · Dimensional ETF Trust 0,00% 37.570 NS 31. Juli 2026 N-PORT
PRFZ · Invesco Exchange-Traded Fund Trust 0,00% 5.322 SH 2. Oktober 2026 Täglich
DCOR · Dimensional ETF Trust 0,00% 2.019 NS 31. Juli 2026 N-PORT
DFUS · Dimensional ETF Trust 0,00% 2.079 NS 31. Juli 2026 N-PORT
DFAC · Dimensional ETF Trust 0,00% 5.600 NS 31. Juli 2026 N-PORT
VXF · VANGUARD INDEX FUNDS 0,00% 115.543 SH 19. August 2026 Täglich
VTI · VANGUARD INDEX FUNDS 0,00% 318.980 SH 19. August 2026 Täglich
VXUS · VANGUARD STAR FUNDS 0,00% 64.351 SH 19. August 2026 Täglich
VGK · VANGUARD INTERNATIONAL EQUITY INDEX… 0,00% 9.806 SH 19. August 2026 Täglich
VT · VANGUARD INTERNATIONAL EQUITY INDEX… 0,00% 3.076 SH 19. August 2026 Täglich
VEA · VANGUARD TAX-MANAGED FUNDS 0,00% 42.929 SH 19. August 2026 Täglich
VSGX · VANGUARD WORLD FUND 0,00% 1.003 SH 19. August 2026 Täglich
SMLF · iShares Trust · 123.005 SH 11. September 2026 Täglich

MED Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial

21
Bewertung · 9 Analysten VERKAUF
Median-Ziel $12.00 +2,3%
0 0,0% Starker Kauf
0 0,0% Kauf
4 44,4% Halten
4 44,4% Verkauf
1 11,1% Starker Verkauf

12-Monats-Kursziel

1 Analysten · 2026-09-27

Mittelwert-Ziel $12.00 +2,3%

Tief$12.00 Mittelwert$12.00 Hoch$12.00

Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen

22

FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.

Ticker Marktkapitalisierung P/E Umsatz Vj. Nettomarge ROE Bruttogewinnmarge
MED $117M -6.3 -36.0% -4.8% -9.0% 71.3%
USNA $355M 33.5 8.3% 1.2% 2.0% 78.3%
NUS · 3.0 -14.3% 10.8% 22.0% 69.5%
NATR $378M 20.4 5.7% 4.1% 12.0% 72.4%
NAGE $507M 31.8 29.9% 13.4% 24.7% 64.3%
UPXI $62M -0.2 58.1% -984.3% 9654.9% 89.5%
FTLF · 25.8 26.4% · · ·
SKIN $177M -8.7 -10.0% -3.2% -14.1% 65.3%
LFVN $78M 15.6 -20.1% 2.8% 15.2% 77.6%

Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten

26

Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.

Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.

Quelle: SEC 10-Q eingereicht Aug 3, 2026